| Outgoing Relation(s) |
| potassium channel blocker (CHEBI:50509) is a potassium channel modulator (CHEBI:50510) |
| Incoming Relation(s) |
| ent-diltiazem (CHEBI:82813) has role potassium channel blocker (CHEBI:50509) |
| ent-diltiazem hydrochloride (CHEBI:82817) has role potassium channel blocker (CHEBI:50509) |
| ent-diltiazem(1+) (CHEBI:82816) has role potassium channel blocker (CHEBI:50509) |
| 2-methoxy-N-[(1-phenylcyclopentyl)methyl]benzamide (CHEBI:233046) has role potassium channel blocker (CHEBI:50509) |
| 4-aminopyridine (CHEBI:34385) has role potassium channel blocker (CHEBI:50509) |
| 4-aminopyridine-3-methanol (CHEBI:149772) has role potassium channel blocker (CHEBI:50509) |
| 5-hydroxydecanoate (CHEBI:234041) has role potassium channel blocker (CHEBI:50509) |
| barium chloride (CHEBI:63317) has role potassium channel blocker (CHEBI:50509) |
| barium chloride dihydrate (CHEBI:86153) has role potassium channel blocker (CHEBI:50509) |
| berberine (CHEBI:16118) has role potassium channel blocker (CHEBI:50509) |
| candelalide A (CHEBI:65571) has role potassium channel blocker (CHEBI:50509) |
| candelalide B (CHEBI:65572) has role potassium channel blocker (CHEBI:50509) |
| candelalide C (CHEBI:65573) has role potassium channel blocker (CHEBI:50509) |
| dofetilide (CHEBI:4681) has role potassium channel blocker (CHEBI:50509) |
| ethyl L-methioninate (CHEBI:131435) has role potassium channel blocker (CHEBI:50509) |
| Guangxitoxin 1E (CHEBI:233846) has role potassium channel blocker (CHEBI:50509) |
| nalanthalide (CHEBI:66610) has role potassium channel blocker (CHEBI:50509) |
| NNC 55-0396 (free base) (CHEBI:194337) has role potassium channel blocker (CHEBI:50509) |
| NNC 55-0396 dihydrochloride (CHEBI:194301) has role potassium channel blocker (CHEBI:50509) |
| paxilline (CHEBI:34907) has role potassium channel blocker (CHEBI:50509) |
| psora 4 (CHEBI:183514) has role potassium channel blocker (CHEBI:50509) |
| quinidine (CHEBI:28593) has role potassium channel blocker (CHEBI:50509) |
| quinidine hydrochloride monohydrate (CHEBI:233595) has role potassium channel blocker (CHEBI:50509) |
| tedisamil (CHEBI:134747) has role potassium channel blocker (CHEBI:50509) |
| tetraethylammonium chloride (CHEBI:78161) has role potassium channel blocker (CHEBI:50509) |
| tetrapropylammonium bromide (CHEBI:55318) has role potassium channel blocker (CHEBI:50509) |
| tolazamide (CHEBI:9613) has role potassium channel blocker (CHEBI:50509) |
| tolbutamide (CHEBI:27999) has role potassium channel blocker (CHEBI:50509) |
| UCL 1684 (CHEBI:35040) has role potassium channel blocker (CHEBI:50509) |
| verruculogen (CHEBI:72765) has role potassium channel blocker (CHEBI:50509) |
| VU041 (CHEBI:232413) is a potassium channel blocker (CHEBI:50509) |
